Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

NCT00021424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Head and Neck Cancer
Metastatic Cancer

Interventions

BIOLOGICAL: recombinant fowlpox-TRICOM vaccine

Sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD)